本页面由Tiger Trade Technology Pte. Ltd.提供服务

LifeStance Health Group, Inc.

12.40
-0.0250-0.20%
成交量:91.09万
成交额:1,135.92万
市值:47.36亿
市盈率:96.21
高:12.54
开:12.45
低:12.38
收:12.42
52周最高:13.56
52周最低:4.77
股本:3.82亿
流通股本:2.76亿
量比:0.52
换手率:0.33%
股息:- -
股息率:- -
每股收益(TTM):0.1288
每股收益(LYR):0.0200
净资产收益率:3.43%
总资产收益率:2.32%
市净率:3.21
市盈率(LYR):619.75

数据加载中...

2026/09/11

重要事件披露

Form 8-K - Current report
2026/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/11

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/07

重要事件披露

Form 8-K - Current report
2026/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities